Body-on-chip system. (Credit: Tel Aviv University)

A team of scientists has devised a functioning comprehensive multiorgan-on-a-chip platform that enables effective in-vitro-to-in-vivo translation (IVIVT) of human drug pharmacology.

In the first of two studies, the scientists developed the “Interrogator,” a robotic liquid transfer device to link individual “Organ Chips” in a way that mimics the flow of blood between organs in the human body. The team applied their Interrogator automated linking platform and a new computational model they developed to three linked organs to test two drugs: nicotine and cisplatin.

The researchers accurately modeled the oral uptake of nicotine and intravenous uptake of cisplatin, a common chemotherapy medication, and their first passage through relevant organs with highly quantitative predictions of human pharmacokinetic and pharmacodynamic parameters.

For more information, visit here .

Topics:
Collaboration and partnering Diagnostics Ingestibles and Lab-on-a-Chip Medical Medical equipment and supplies Medical, health and wellness Medical, health, and wellness People and personalities Pharmaceuticals Test equipment and instrumentation

More From SAE Media Group

Medical Design Briefs
Researchers Grow Stem Cells on a Chip
Related article image
Medical Design Briefs
Microfluidic Chip Tests Drug Sensitivity
Related article image
Medical Design Briefs
Microfluidics Device Can Detect Cancer Cells in Blood
Related article image
Medical Design Briefs
New Device Quickly Detects Lithium Ions in Blood of Bipolar Disorder Patients
Related article image
    Magazine cover
    Medical Design Briefs Magazine

    This article first appeared in the March, 2020 issue of Medical Design Briefs Magazine.

    Read more articles from this issue here.

    Read more articles from the archives here.